Expression of PHF19 was reported as significantly associated with MM disease progression, showing a predictive value greater than NSD2 [47], an oncogene frequently over-expressed in MM plasma cells harboring the high-risk t(4;14) translocation; and reported to modulate by the oncogene NSD2 [48]. This evidence concerns the gene PHF19 and Miyoshi myopathy.